Financials

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Financials

Edelweiss is a small-cap (~$1.24B market cap) Indian diversified financial holdco that has spent six years rebuilding from a near-death FY20 ($270M loss after the IL&FS/DHFL NBFC bust) into a leaner, lower-leverage, fee-and-recovery-driven group. Revenue has stabilised in a $1.0–1.5B band post the FY21 Nuvama Wealth demerger, operating margin has reset from a 60% "lending-spread" model to a 30–36% "mixed fee + recovery + insurance" model, FY26 PAT of $73M is up 27% YoY but still well below the FY19 peak of $151M, and borrowings have been cut by 74% from the FY18 peak of $7.51B to $1.98B. The single financial metric that matters most right now is return on equity post-minority-interest: at ~11.8% it sits below every fee-heavy peer (Motilal 15.6%, 360 ONE 14.4%) and is the gate that has to clear before the 2.5× P/B re-rates.

1. Financials in one page

2. Revenue, margins, and earnings power

Revenue here is consolidated total income from operations — interest income on the lending book plus fee income from broking, asset management, ARC distributions, and insurance premiums net of claims. Because the mix shifts every year (more insurance + ARC in recent years, less NBFC + wealth after the Nuvama demerger), the level of revenue is less informative than the quality of the margin underneath it.

The shape of this chart is the entire story. FY15–FY19 was the boom: revenue compounded at 30% per year as the group ran a leveraged NBFC book at 60% operating margins. FY20 was the wreck: revenue fell 14%, operating margin collapsed from 59% to 26%, and the company posted a $270M loss as IL&FS/DHFL contagion forced credit costs and provisions through the book. FY21–FY24 was the reset: the company sold majority stakes in wealth management (to PAG, ~$324M, FY21) and demerged what is now Nuvama Wealth (FY24), which is why revenue and margin both rebased lower. FY25–FY26 is the post-reset run-rate: revenue $1.1–1.1B, operating margin 30–36%, PAT modestly recovering toward (but still well below) the FY19 peak.

Interest expense is the dominant cost line — $266M in FY26, equal to 24% of revenue and 81% of operating profit. The structural margin compression versus FY15–FY19 is not because the business got worse; it is because the mix changed away from spread-lending toward lower-revenue/higher-cost fee businesses (ARC, alternatives, insurance), while interest expense did not fall as fast as borrowings. Operating margin recovered to 36% in FY25 but slipped back to 30% in FY26 as the asset-management and credit segments absorbed cost while the recovery cycle in EARC slowed.

The quarterly view exposes two things the annual chart hides. Q3 FY26 (Oct–Dec 2025) was anomalously large — revenue $490M versus a typical $220–290M — almost certainly driven by a lumpy ARC recovery or one-time investment gain (operating margin actually fell to 27% that quarter despite the revenue spike, meaning the gain came with offsetting cost or was concentrated in low-margin lines). Q4 FY26 (Jan–Mar 2026) gave it back — revenue dropped 58% sequentially to $205M, operating margin to 26%, and the stock fell ~10% on the print. This is not a clean compounder; it is an event-driven mix that needs to be modelled with the lumpiness in.

3. Cash flow and earnings quality

Free cash flow is operating cash flow minus capital expenditure. For a financial holdco the textbook definition is partially misleading because "operating cash flow" includes the change in loans and investments — when the loan book grows, CFO looks awful even if earnings are real; when the book shrinks, CFO looks heroic even if it is just balance-sheet contraction.

Three regimes show up clearly. FY15–FY18 (book-growth phase): deeply negative CFO because the company was deploying $1.4–2.0B a year into the lending book; financing inflows funded it. FY19–FY22 (book-shrinkage phase): massively positive CFO (peak $1,599M in FY20) because the company was running off the wholesale book and recovering capital — this is the inverse of earnings quality, not the same thing. FY23–FY26 (steady-state phase): CFO of $96–352M that more closely tracks reported PAT. The ratio of CFO to operating profit was 65% in FY25, fell to 40% in FY26 — a yellow flag if it persists, because it would suggest a chunk of FY26 earnings sat in receivables (e.g. ARC distributions yet to be received, security receipts not yet redeemed) or in non-cash mark-to-market.

Cash conversion was 90–180% for FY19–FY24 (a healthy range for a deleveraging NBFC), but the slide to 65% in FY25 and 40% in FY26 is the single most actionable signal in this page. Either the company is starting to grow the book again — in which case CFO will stay depressed structurally and that is fine — or it is recognising earnings (e.g. ARC fair-value step-ups, insurance value-of-new-business) that take longer to turn into cash. Watch which one in the next print.

4. Balance sheet and financial resilience

For a financial holdco the balance sheet is the business. The relevant questions are: how much debt sits in the operating subsidiaries, how does the group fund itself, what is the asset quality of the underlying loan/recovery book, and what credit ratings have the rating agencies anchored to.

The deleveraging is real and unambiguous: borrowings down 74% from the FY18 peak of $7.51B to $1.98B (the larger percentage decline in USD vs INR reflects rupee depreciation over the same period). Equity is also lower than at peak ($493M vs $1.11B in FY19) because losses, demerger value-outs, and capital returns have absorbed retained earnings. The result is a smaller balance sheet — total assets $4.66B, roughly half of the FY18 maximum measured in dollars — running at a more sustainable leverage. ICRA's December 2025 rating action anchored consolidated gearing at 3.5× (excluding collateralised borrowing) as of September 2025, with a reaffirmed [ICRA]A+ (Stable) on the retail NCDs; CRISIL holds the parallel CRISIL A+/Stable. Both ratings sit two notches below the FY22 AA- — a level the company has not regained.

Interest coverage is the cleanest single measure of resilience for this kind of business. Coverage dropped to 0.52× in FY20 — the operating book did not earn enough to pay its own interest — which is what triggered the crisis. It has rebuilt to 1.24× by FY26, but that is still thin: a 25% drop in operating profit (e.g. a single bad ARC recovery year) would push coverage back below 1×. This is why both rating agencies kept the A+ floor rather than upgrading after the loan-book deleveraging.

5. Returns, reinvestment, and capital allocation

ROCE rebuilt from 5% (FY20) to 14% (FY26) — the highest level in the 12-year history. That is the bull case in one number: the structurally smaller, less-levered group earns a better return on capital than the larger, more-levered version did pre-crisis. The caveat is that ROCE includes minority interest at the numerator and denominator; the per-share economic return to public shareholders (ROE post-MI ~11.8%) is materially lower because external strategic investors (PAG-era stakes, CDPQ, Kora) take a share of the same earnings stream.

Capital allocation has been defensive, not aggressive. Share count has held essentially flat at ~947M (no large rights issue, no buyback). FY26 dividend was $0.016 per share — a 26% payout on the post-MI PAT and ~1.21% yield at the current price. The visible cash uses since FY20 have been (1) deleveraging — over $4B of debt repaid, (2) selectively monetising stakes in subsidiaries to global investors (PAG, CDPQ, Kora) rather than diluting public equity, and (3) the FY24 Nuvama demerger that handed shareholders a separately-listed wealth franchise. Reinvestment economics: the FY26 14% ROCE is good enough to justify reinvestment, but management has signalled it will continue to "monetise to deleverage" rather than redeploy at scale — which keeps growth modest.

6. Segment and unit economics

Segment-level financials (revenue and profit by Asset Management, Credit, Insurance, ARC, Capital Markets) are disclosed in the annual report and earnings call but were not delivered in the structured data feed for this run, so the chart-grade breakdown is unavailable here. What can be said from the FY26 earnings call commentary and ICRA's December 2025 review:

• Asset Management (alternatives + mutual funds) is the fee-revenue engine and the segment management cites most prominently as the growth lever; AUM in alternatives has been the headline number in earnings releases.
• EARC (asset reconstruction) is the lumpy-but-high-return engine; FY26 results commentary attributes much of the PAT growth to ARC recoveries.
• Insurance (Edelweiss Life, Edelweiss General) absorbs capital and is loss-making at the segment level but the value-of-new-business is growing; the life book is the longest-duration asset in the holdco.
• Credit (Nido Home Finance, ECL Finance, MSME) is the segment that was most affected by the FY24 RBI restrictions; the AUM here has been steady at ~$1.3B (ICRA estimate, H1 FY26).

The bottleneck on this section is data — the next iteration of this page should pull the segment-revenue split from the FY26 annual report directly.

7. Valuation and market expectations

For a diversified financial holdco the right valuation metric is P/B benchmarked against ROE, not P/E. P/E is distorted by minority interest and by the lumpy contribution of ARC recoveries; P/B and ROE travel together in a way that absorbs both.

The 21.5× P/E today is at the upper end of the post-crisis range (FY21–FY26 has cycled in a 14–23× band). On P/B, 2.54× is also at the upper end of the company's own history. The market is paying for the deleveraging story being complete, the RBI restrictions being lifted, and the EARC + alternatives franchises being intact. What it is not yet paying for is sustained 14%+ ROE post-MI — the most recent print is 11.8%, so the stock is priced to clear the ROE bar that the numbers do not yet show.

At $1.31, the stock is roughly mid-range of the base case. Asymmetry is modest: ~17% downside to the bottom of base, ~17% upside to the top of base, and the bull case (a meaningful re-rating on a sustained ROE pickup and a CRISIL/ICRA upgrade) is ~75% upside but requires both legs.

8. Peer financial comparison

The peer set sorts cleanly into two valuation buckets that match the economic-fact of the businesses:

• The "balance-sheet leveraged + ARC + NBFC" cluster — Edelweiss, JM Financial, IIFL Finance — trades at 1.3–2.5× P/B with 9–13% ROE. These are spread-and-recovery businesses; the market discounts them because earnings are lumpy and credit cycle exposed.
• The "fee-asset-management + wealth" cluster — Motilal Oswal, 360 ONE — trades at 4.1–4.6× P/B with 14–16% ROE. These are scalable, capital-light fee businesses that the market pays a structural premium for.
• Aditya Birla Capital sits in the middle — large, diversified, and pricing for an eventual mix-shift toward fee.

Edelweiss already trades at a premium to the closest pure-NBFC peers (P/B 2.54 vs JM 1.31 / IIFL 1.42) despite ROE that is barely higher. The market is paying it as a partial fee-business comp — credit for the EARC and AMC franchises — but it has not closed the gap to Motilal/360 ONE. The premium is half-paid, half-deserved: paid because the deleveraging happened; deserved if-and-only-if the fee mix continues to grow share and ROE post-MI breaks above 13%.

9. What to watch in the financials

What the financials confirm. Deleveraging is real (borrowings down 74% from peak), ROCE rebuilt to a 12-year high of 14%, FY26 PAT pre-MI grew 27%, and the credit rating has stabilised at A+ across CRISIL and ICRA. The post-FY20 reset is, in numerical terms, complete.

What they contradict. The 21.5× P/E and 2.54× P/B are pricing a fee-business franchise that the post-MI ROE (11.8%) does not yet justify. Cash conversion has weakened to 40% in FY26 from 65% in FY25. Quarterly revenue is highly lumpy. Interest coverage at 1.24× is still thin.

The first financial metric to watch is the post-minority-interest ROE in the FY27 print — if it breaks above 13% on a clean (non-lumpy) revenue base, the 2.5× P/B re-rates toward the fee-peer 3.5–4×; if it slips back below 10%, the 2.5× P/B compresses toward the JM Financial 1.3× anchor.